Edition:
United Kingdom

Galmed Pharmaceuticals Ltd (GLMD.OQ)

GLMD.OQ on NASDAQ Stock Exchange Capital Market

8.66USD
13 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.66
Open
$9.35
Day's High
$9.35
Day's Low
$8.40
Volume
28,113
Avg. Vol
28,946
52-wk High
$27.06
52-wk Low
$3.61

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.14 December 14 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 6 6 7 7
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.86 1.86 1.88 1.88

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.17 0.30 0.00 0.22
Quarter Ending Mar-19 5 0.09 0.28 0.00 --
Year Ending Dec-18 6 2.17 2.34 2.00 0.81
Year Ending Dec-19 7 0.53 2.00 0.00 6.00
Earnings (per share)
Quarter Ending Dec-18 6 -0.14 -0.09 -0.19 -0.21
Quarter Ending Mar-19 5 -0.18 -0.11 -0.32 --
Year Ending Dec-18 6 -0.52 -0.41 -0.61 -0.79
Year Ending Dec-19 7 -1.03 -0.72 -1.70 -0.91

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.14 1.50 1.36 958.57
Quarter Ending Jun-18 0.27 0.27 0.00 0.48
Quarter Ending Mar-18 0.30 0.27 0.03 10.67
Quarter Ending Dec-17 0.29 0.27 0.02 5.19
Quarter Ending Sep-17 0.32 0.27 0.05 14.37

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.17 0.17 0.17 0.19 0.22
Quarter Ending Mar-19 0.09 0.09 0.09 0.09 --
Year Ending Dec-18 2.17 2.17 0.78 0.82 0.81
Year Ending Dec-19 0.53 0.53 0.53 0.53 6.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 6 0
Year Ending Dec-19 0 0 0 0
Earnings